Takeda Pharmaceutical Co Ltd (OTCPK:TKPHF)
$ 28.6 0 (0%) Market Cap: 44.77 Bil Enterprise Value: 71.99 Bil PE Ratio: 23.21 PB Ratio: 0.98 GF Score: 78/100

Full Year 2023 Takeda Pharmaceutical Co Ltd Earnings Presentation Transcript

May 11, 2023 / 10:00AM GMT
Release Date Price: $32.5 (-5.70%)

May 11, 2023 / 10:00AM GMT
Presentation
May 11, 2023 / 10:00AM GMT

=====================
Corporate Participants
=====================
* Andrew S. Plump
Takeda Pharmaceutical Company Limited - President of Research & Development and Representative Director
* Christophe Weber
Takeda Pharmaceutical Company Limited - President, CEO & Representative Director
* Christopher David O'Reilly
Takeda Pharmaceutical Company Limited - Global Head of IR & Global Finance
* Constantine Saroukos
Takeda Pharmaceutical Company Limited - CFO & Representative Director
* Giles Platford
Takeda Pharmaceutical Company Limited - President of the Plasma-Derived Therapies Business Unit
* Julie Kim
Takeda Pharmaceutical Company Limited - President of the U.S. Business Unit & U.S. Country Head
* Ramona Sequeira
Takeda Pharmaceutical Company Limited - President of Global Portfolio Division

=====================
Conference Call Participants
=====================
* Hidemaru Yamaguchi
Citigroup Inc.,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot